ArticleMolecular therapy. Nucleic acids2019

The Chromatin Structure of CRISPR-Cas9 Target DNA Controls the Balance between Mutagenic and Homology-Directed Gene-Editing Events.

Josephine M Janssen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.